Applications of the neutral red cytotoxicity assay to in vitro toxicology

By Babich, H. - Borenfreund, E.

A concerted effort is currently in progress to develop alternatives to the use of live animals for the acute toxicity testing of xenobiotics. To this end, the neutral red in vitro cytotoxicity assay was developed which, although initially based on the use of mammalian cells in culture, has also been adapted for ecotoxicity studies using fish cells in culture. The neutral red assay is based on the binding of neutral red, a weakly cationic supravital dye, to the lysosomal matrix of viable cells after their incubation with toxic agents. Spectrophotometric quantitation of the extracted dye with a scanning microtitre well reader at 540 nm was found to be linear with the number of surviving, viable cells. The assay has been used to determine the relative acute cytotoxicities of a broad spectrum of chemical test agents, to establish structure-toxicity relationships for series of related chemicals, to study metabolism-mediated cytotoxicity, to evaluate interactions between combinations of test agents, to evaluate differential and selective toxicities of cancer chemotherapeutics and other pharmaceuticals, and to study temperature-toxicity interactions.



Issued: Nov 1990

Journal Title: Alternatives to laboratory animals

ISSN: 0261-1929

Volume issue: 18 v.

Pages: 129 - 144

AGRICOLA identifier: IND20359836
This page was updated on 11 February 2021
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!

Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.

Hva lette du etter?

Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.

Kontakt oss gjerne på e-post hvis du har spørsmål.

Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.

RadioButtonList field
 

Abonnér på nyhetsbrevene fra Norecopa